"NIAID worked expeditiously to ready a vaccine candidate, and results in animal testing have been very encouraging," Fauci said in a statement. "We are pleased that we are now able to proceed with this initial study in people. Although it will take some time before a vaccine against Zika is commercially available, the launch of this study is an important step forward."